Ultimately, this is not just an operational issue delays in securing manufacturing capacity can directly erode programme value by pushing out launch timelines and impacting revenue realisation
And yet, Ive opted outnot because I feel sanctimonious about pursuing my weight-loss goals without medication (which I am), or because I think taking GLP-1s is somehow cheating or taking the easy way out (I dont, and its not), but because even though doctors have suggested I try the drugs, Im concerned about certain effects of a treatment thats only become mainstream for weight loss fairly recently
Instead, it is best assessed by evaluating a variety of factors, including blood pressure, visceral fat, cholesterol levels (ApoB, Triglycerides, and HDL cholesterol), markers of inflammation, muscle mass, physical strength, bone density, and cardiorespiratory fitness
Current FDA Context Around Compounded GLP-1 Medications This is information that most competing pages in this space do not cover clearly, and it matters